Air Liquide Medical Systems is continually involved in research to achieve significant improvements in the development of Inhalation Therapy.
Believing firmly in the benefits of topical and local therapy, the company was the first in
L'espace is the new spacer chamber designed, developed and built entirely by Air Liquide Medical Systems to enhance treatment with all MDIs (metered dose inhalers), a new breakthrough in terms of research and the development of devices to meet the needs of both patients and doctors.
Full details of our products are provided on the following pages. In viewing them, it is important to bear the following points in mind.
Our nebulizers are tested with the main drugs to assess their reliability and, more importantly, their ability to distribute the drug in a way consistent with the manufacturer's indications.
· We also provide some references to the scientific documentation providing evidence of the effectiveness of our products.
· You are advised to read the brief sections on aerosol therapy since its effectiveness depends not only on the device used but also on the result of the application and a knowledge of some rules of use and behaviour.
Air Liquide Medical Systems S.p.A.
Via Dei Prati 62
25073 Bovezzo (Brescia)
Tel. +39 030 20 159 11
Fax +39 030 20 98 329
By e-mail :
Click here